Hantavirus infection differential diagnosis: Difference between revisions
Ahmed Younes (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
Line 331: | Line 331: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Needs content]] | |||
[[Category:Viral diseases]] | [[Category:Viral diseases]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Emergency mdicine]] | |||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] |
Latest revision as of 21:57, 29 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Hemorrhagic fever caused by hantavirus can be differentiated from other disease such as dengue, malaria and Ebola. The hantavirus cardiopulmonary syndrome can be differentiated from other diseases like histoplasmosis, coccidioidomycosis, brucellosis, tuberculosis and aspergillosis.
Differentiating Hantavirus infection from other Diseases
Hemorrhagic fever caused by hantavirus can be differentiated from other disease such as dengue, malaria and Ebola. The hantavirus cardiopulmonary syndrome can be differentiated from other diseases like histoplasmosis, coccidioidomycosis, brucellosis, tuberculosis and aspergillosis.
Differentiating Hantavirus infection from other causes of Hemorrhagic fever
Disease | Incubation period | Vector | Symptoms | Physical signs | Lab findings | Other findings | Treatment | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Cough | Rash | Joint pain | Myalgia | Diarrhea | Common hemorrhagic symptoms | Characterestic physical finding | Icterus | Plasma Creatine kinase | Confirmatory test | |||||
Leptospirosis | 2 to 30 days | Rodents
Domestic animals |
Fever last for 4-7 days, remission for 1-2 days and then relapse | + | Present over legs Hemorrhagic rash | + | +
(Severe myalgia is characteristic of leptospirosis typically localized to the calf and lumbar areas) |
+ | Conjunctival hemorrhage, | Conjunctival suffusion | + | Elevated | Microscopic agglutination test of urine | History of exposure to soil or water
contaminated by infected rodents Recent history travel to tropical, sub tropical areas or humid areas |
NSAIDs |
Dengue | 4 to 10 days | Aedes mosquito | Fever last for 1-2 days,
remission for 1-2 days and then relapse for 1-2 days (Biphasic fever pattern) |
- | Over legs and trunk
pruritic rash May be hemorrhagic |
+ | + | - | Upper gastrointestinal bleeding | Painful lymphadenopathy | - | Normal | Serology showing positive IgM or IgG | Recent travel to South America, Africa, Southeast Asia | Supportive care
Avoid aspirin and other NSAIDs |
Malaria |
|
Female Anopheles | Fever present daily or on alternate day or every 3 days depending on Plasmodium sps. | - | No rash | - | + | - | Bloody urine | Hepatosplenomegaly | + | Normal | Giemsa stained thick and thin blood smears | Recent travel to South America, Africa, Southeast Asia | Anti malarial regimen |
Ebola | 2 to 21 days. | No vector
Human to human transmission |
+ | + | Maculopapular
non-pruritic rash with erythema Centripetal distribution |
+ | + | +
May be bloody in the early phase |
Epistaxis | Sudden onset of high fever with conjunctival injection and early gastrointestinal symptoms | - | Normal | RT-PCR | Recent visit to endemic area especially African countries | Isolation of the patient,
supportive therapy |
Influenza | 1-4 days | No vector | + | + | +/- | + | + | + | - | Fever and upper respiratory symptoms | - | Normal | Viral culture or PCR | Health care workers
Patients with co-morbid conditions |
Symptomatic treatment |
Yellow fever | 3 to 6 days | Aedes or Haemagogus species mosquitoes | + | + | - | - | + | - | Conjunctival hemorrhage, | Relative bradycardia | + | Normal | RT-PCR, | Recent travel to Africa, South and Central America, and the Caribbean.
Tropical rain forests of south America |
Symptomatic treatment, |
Typhoid fever | 6 to 30 days | No vector | + | - | Blanching erythematous
maculopapularlesions on the lower chest and abdomen |
+ | + | + | Intestinal bleeding | Rose spots | - | Normal | Blood or stool culture showing salmonella typhi sps. | Residence in endemic area
Recent travel to endemic area |
Fluoroquinolones, |
Differentiating Hantavirus infection on the basis of Cardiopulmonary involvement
The hantavirus cardiopulmonary syndrome can be differentiated from other diseases like histoplasmosis, coccidioidomycosis, brucellosis, tuberculosis and aspergillosis.
Disease | Geographic distribution | High risk Groups | Differentiating features | Microscopic findings | |
---|---|---|---|---|---|
Physical exam | Laboratory findings | ||||
Histoplasmosis | Mississippi and Ohio River valleys |
|
|
Yeast are typically smaller, with narrow-based budding, found intracellularly within macrophages | |
Coccidioidomycosis | Southwestern US region | Opportunistic infection seen in AIDS |
|
Serologic tests (enzyme immune assay) more sensitive | Characteristic spherule appearance |
Aspergillosis[3] | Ubiquitous |
|
Cell wall detection using galactomannan antigen detection, Beta-D-glucan detection test. | Septated hyphae with acute angle branching | |
Anthrax | Ubiquitous | Live stock handlers |
|
|
Nonmotile, Gram-positive, aerobic or facultatively anaerobic, endospore-forming, rod-shaped bacterium |
Tuberculosis | Asia,Africa | Ill contact individuals |
|
Aerobic, non-encapsulated, non-motile, acid-fast bacillus | |
Listeriosis | Ubiquitous | Pregnant women [5]
Adults > 65 |
|
|
flagellated, catalase-positive, facultative intracellular, anaerobic, nonsporulating, Gram-positive bacillus |
Brucellosis |
Mexico, South and Central America |
People who take unpasteurized dairy products |
|
Gram-negative bacteria,non-motile, encapsulated coccobacilli. | |
Coxsackie A virus | − | Children attending day care[6] | Painful blisters in the mouth, palms and on the feet.
Rash, appears after episode of high fever. |
Clinically diagnosed | − |
References
- ↑ Information for Healthcare Professionals about Histoplasmosis. Centers for Disease Control and Prevention. 2015. Available at: http://www.cdc.gov/fungal/diseases/histoplasmosis/health-professionals.html. Accessed February 2, 2016.
- ↑ Brown J, Benedict K, Park BJ, Thompson GR (2013). "Coccidioidomycosis: epidemiology". Clin Epidemiol. 5: 185–97. doi:10.2147/CLEP.S34434. PMC 3702223. PMID 23843703.
- ↑ Sherif R, Segal BH (2010). "Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications". Curr Opin Pulm Med. 16 (3): 242–50. doi:10.1097/MCP.0b013e328337d6de. PMC 3326383. PMID 20375786.
- ↑ Hicks CW, Sweeney DA, Cui X, Li Y, Eichacker PQ (2012). "An overview of anthrax infection including the recently identified form of disease in injection drug users". Intensive Care Med. 38 (7): 1092–104. doi:10.1007/s00134-012-2541-0. PMC 3523299. PMID 22527064.
- ↑ Lamont RF, Sobel J, Mazaki-Tovi S, Kusanovic JP, Vaisbuch E, Kim SK, Uldbjerg N, Romero R (2011). "Listeriosis in human pregnancy: a systematic review". J Perinat Med. 39 (3): 227–36. doi:10.1515/JPM.2011.035. PMC 3593057. PMID 21517700.
- ↑ Flett K, Youngster I, Huang J, McAdam A, Sandora TJ, Rennick M, Smole S, Rogers SL, Nix WA, Oberste MS, Gellis S, Ahmed AA (2012). "Hand, foot, and mouth disease caused by coxsackievirus a6". Emerging Infect. Dis. 18 (10): 1702–4. doi:10.3201/eid1810.120813. PMC 3471644. PMID 23017893.